42 related articles for article (PubMed ID: 2160247)
1. Electrostatic requirements for high benzodiazepine receptor affinity among betacarboline-3-carboxylic acid derivatives.
Gynther J; Konschin H; Tylli H; Rouvinen J
Acta Pharm Nord; 1990; 2(1):45-52. PubMed ID: 2160247
[TBL] [Abstract][Full Text] [Related]
2. Theoretical structure-activity studies of beta-carboline analogs. Requirements for benzodiazepine receptor affinity and antagonist activity.
Loew GH; Nienow J; Lawson JA; Toll L; Uyeno ET
Mol Pharmacol; 1985 Jul; 28(1):17-31. PubMed ID: 2862573
[TBL] [Abstract][Full Text] [Related]
3. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
4. A structure-activity relationship study of the affinity of selected imidazo[1,2-a]pyridine derivatives, congeners of zolpidem, for the omega 1-subtype of the benzodiazepine receptor.
Lange J; Karolak-Wojciechowska J; Wejroch K; Rump S
Acta Pol Pharm; 2001; 58(1):43-52. PubMed ID: 11370287
[TBL] [Abstract][Full Text] [Related]
5. Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity.
Loew GH; Nienow JR; Poulsen M
Mol Pharmacol; 1984 Jul; 26(1):19-34. PubMed ID: 6087115
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3-(2'-furoyl)indole derivatives as potential new ligands at the benzodiazepine receptor, structurally more restrained analogues of indoleglyoxylylamides.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Martini C; Senatore G; Lucacchini A
Farmaco; 1995 May; 50(5):311-20. PubMed ID: 7626165
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1996 Dec; 39(26):5083-91. PubMed ID: 8978839
[TBL] [Abstract][Full Text] [Related]
9. A geometry optimization and molecular electrostatic potential mapping study of structure-activity relationship for some anti-Alzheimer agents.
Kushwaha PS; Shukla MK; Mishra PC
Indian J Biochem Biophys; 1999 Apr; 36(2):101-6. PubMed ID: 10549169
[TBL] [Abstract][Full Text] [Related]
10. 1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations.
Biagi G; Giorgi I; Livi O; Scartoni V; Velo S; Lucacchini A; Senatore G; De Santis B; Martinelli A
Farmaco; 1996 Feb; 51(2):131-6. PubMed ID: 8857209
[TBL] [Abstract][Full Text] [Related]
11. Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
Bioorg Med Chem; 2008 Apr; 16(8):4471-89. PubMed ID: 18325771
[TBL] [Abstract][Full Text] [Related]
12. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
[TBL] [Abstract][Full Text] [Related]
13. Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach.
Allen MS; LaLoggia AJ; Dorn LJ; Martin MJ; Costantino G; Hagen TJ; Koehler KF; Skolnick P; Cook JM
J Med Chem; 1992 Oct; 35(22):4001-10. PubMed ID: 1331452
[TBL] [Abstract][Full Text] [Related]
14. N-benzhydryl-tryptamines and 1,1-diphenyl-tetrahydro-beta-carbolines: synthesis, X-ray crystal structure and benzodiazepine receptor affinity.
Balsamini C; Spadoni G; Duranti E; Cerrini S; Lamba D; Fedeli W
Farmaco; 1989 Apr; 44(4):399-413. PubMed ID: 2550017
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and benzodiazepine receptor affinity of derivatives of the new tricyclic heteroaromatic system pyrido[3',2':5,6]thiopyrano[4,3-c]pyridazin-3(2H,5H)-one.
Primofiore G; Da Settimo F; Marini AM; Simorini F; La Motta C; Taliani S; Laneri S; Trincavelli L; Martini C
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):126-32. PubMed ID: 15799013
[TBL] [Abstract][Full Text] [Related]
16. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.
Borea PA; Gilli G; Bertolasi V; Ferretti V
Mol Pharmacol; 1987 Apr; 31(4):334-44. PubMed ID: 3033465
[TBL] [Abstract][Full Text] [Related]
17. Structure and IR spectrum of phenylalanyl-glycyl-glycine tripetide in the gas-phase: IR/UV experiments, ab initio quantum chemical calculations, and molecular dynamic simulations.
Reha D; Valdés H; Vondrásek J; Hobza P; Abu-Riziq A; Crews B; de Vries MS
Chemistry; 2005 Nov; 11(23):6803-17. PubMed ID: 16092140
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
19. Use of molecular electrostatic potentials for analysis of anticonvulsant activities of phenylsuccinimides.
Kwiatkowski W; Karolak-Wojciechowska J
SAR QSAR Environ Res; 1993; 1(2-3):233-44. PubMed ID: 8790636
[TBL] [Abstract][Full Text] [Related]
20. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
